Fed. Circ. Affirms Generics' Win In Kidney Drug Patent Suit
The Federal Circuit on Thursday upheld a win for generic-drug makers accused of infringing a Roxane Laboratories Inc. kidney medication patent, ruling a district court was right to find that the...To view the full article, register now.
Already a subscriber? Click here to view full article